Heart disease biotech Tenaya Therapeutics files for a $100 million IPO

Tenaya Therapeutics, a preclinical biotech developing multiple therapies to treat heart disease, filed on Friday with the SEC to raise up to $100 million.The company’s multi-modality drug discovery platform targets both genetic and non-genetic forms of heart disease, and consistsRead More